USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
Authors:
Open Access
- 30 January 2025
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-18
Abstract
Intracellular membraneless organelles formed by liquid-liquid phase separation (LLPS) function in diverse physiological processes and have been linked to tumor-promoting properties. The nucleolus is one of the largest membraneless organelle formed through LLPS. Deubiquitylating enzymes (DUBs) emerge as novel therapeutic targets against human cancers. However, the nucleolar phase separation of DUBs and association with lung cancer development have remained incompletely investigated till now. GFP-USP39 fusion proteins were analyzed for LLPS properties using immunofluorescence, fluorescence recovery after photobleaching (FRAP) and in vitro LLPS assays. Intrinsically-disordered regions of USP39 were analyzed by PhaSepDB database. Transcriptomic profiling, Western blot, RT-PCR and luciferase reporter assays were conducted to identify targets regulated by USP39. The effects of USP39 depletion on tumor progression were tested using doxycycline-inducible USP39 knockdown and rescue lung adenocarcinoma cells both in vitro and in vivo by performing MTT, colony formation, EdU staining, transwell and tumor xenograft model experiments. USP39 phase separates into nucleoli depending upon its N-terminal disordered region with amino acid residues 1-103. Lung cancer cell growth and migration were dramatically inhibited by USP39 knockdown, which was rescued by exogenous USP39 complementation. Moreover, knockdown of USP39 reduced oncogenic transcription effector GLI1 levels. Finally, USP39 downregulation restricted the formation of lung cancer xenografts in nude mice. USP39 undergoes LLPS in the nucleolus and promotes tumor progression by regulating GLI1 expression. Downregulation of USP39 effectively suppressed lung cancer growth, and therefore targeting USP39 provides novel therapeutic strategy to treat lung cancer.Keywords
Funding Information
- Department of Education of Liaoning Province (LJKMZ20221275, LJKZ0829)
- National Natural Science Foundation of China (82103146)
- China Postdoctoral Science Foundation (2020M680921)
- Department of Science and Technology of Liaoning Province (2024-MS-150)
This publication has 55 references indexed in Scilit:
- Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular CondensatesCell, 2019
- Biomolecular condensates: organizers of cellular biochemistryNature Reviews Molecular Cell Biology, 2017
- EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen ReceptorACS Chemical Biology, 2016
- Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongationOncotarget, 2016
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian CarcinomasCancer Cell, 2016
- The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-MycProceedings of the National Academy of Sciences, 2015
- Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functionsMolecular Biology of the Cell, 2012
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36Journal of Cell Science, 2009
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora BCell Cycle, 2008